Telephone
61.7.3367.7900
Address
Milton Level 2 299 Coronation Drive Brisbane, Queensland (QLD) 4064
Description
ALS Ltd. engages in the analytical and testing services businesses and partnerships. It operates through the following segments: Life Sciences, Commodities, Industrial, and Other. The Life Sciences segment is involved in analytical testing data to assist consulting and engineering firms, industry, and governments in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health. The Commodities segment includes assaying and analytical testing and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry such as coal sampling, analysis and certification, and formation evaluation services. The Industrial segment focuses on energy, resources, and infrastructure sectors with asset care and tribology testing services. The company was founded in 1863 and is headquartered in Brisbane, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 10.52 - 13.48
Trade Value (12mth)
AU$2,951,026.00
1 week
3.43%
1 month
15.93%
YTD
5.06%
1 year
3.6%
All time high
14.14
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
487m
HALO Sector
Industrials
Next Company Report Date
21-May-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.46
Date | Announcements |
---|---|
31 October 22 |
Change of Registry Address
×
Change of Registry Address |
31 May 16 |
Investor Day Presentation, ALS Life Sciences - Melbourne
×
Investor Day Presentation, ALS Life Sciences - Melbourne |
30 November 10 |
First Half FY2011 Results Presentation (CPB-AU)
×
First Half FY2011 Results Presentation (CPB-AU) |
30 May 18 |
Audio of FY2018 Results Investor Presentation
×
Audio of FY2018 Results Investor Presentation |
30 May 16 |
Investor Presentation - FY2016 Results
×
Investor Presentation - FY2016 Results |
30 June 22 |
HRL: HRL Enters Into Bid Implementation Agreement With ALS
×
HRL: HRL Enters Into Bid Implementation Agreement With ALS |
30 June 22 |
ALS enters into Bid Implementation Deed with HRL
×
ALS enters into Bid Implementation Deed with HRL |
30 June 22 |
Becoming a substantial holder for HRL
×
Becoming a substantial holder for HRL |
30 June 22 |
DRP Price for Final Dividend FY22
×
DRP Price for Final Dividend FY22 |
30 July 18 |
Annual Report 2018 - correction
×
Annual Report 2018 - correction |
30 July 18 |
Annual Report 2018 - amended
×
Annual Report 2018 - amended |
30 July 13 |
AGM 30 July 2013 - Chairman\'s and MD\'s Presentation
×
AGM 30 July 2013 - Chairman\'s and MD\'s Presentation |
29 November 16 |
Investor Presentation First Half Results FY2017
×
Investor Presentation First Half Results FY2017 |
29 May 23 |
ALS Full Year Statutory Accounts FY23
×
ALS Full Year Statutory Accounts FY23 |
29 May 23 |
ALS Full Year Results FY23
×
ALS Full Year Results FY23 |
29 May 23 |
ALS Investor Presentation FY23
×
ALS Investor Presentation FY23 |
29 May 23 |
Dividend/Distribution - ALQ
×
Dividend/Distribution - ALQ |
29 March 23 |
ALS Trading Update
×
ALS Trading Update |
29 June 12 |
Campbell Brothers Limited - Notice of Annual General Meeting/Proxy Form (CPB-AU)
×
Campbell Brothers Limited - Notice of Annual General Meeting/Proxy Form (CPB-AU) |
29 June 12 |
Campbell Brothers Limited - Annual Report to shareholders (CPB-AU)
×
Campbell Brothers Limited - Annual Report to shareholders (CPB-AU) |
29 June 07 |
Annual Report 2007
×
Annual Report 2007 |
29 June 07 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
28 May 18 |
Investor Presentation FY2018 Results
×
Investor Presentation FY2018 Results |
28 May 15 |
Investor Presentation FY2015 Results
×
Investor Presentation FY2015 Results |
28 June 22 |
Response to media speculation - HRL Holdings
×
Response to media speculation - HRL Holdings |
28 June 22 |
HRL:Receipt of Non-Binding Indicative Offer from ALS Limited
×
HRL:Receipt of Non-Binding Indicative Offer from ALS Limited |
28 June 13 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.